AMRI (AMRI) and PerkinElmer (PKI) Announce Drug Discovery Collaboration as Part of the Buffalo Medical Innovation and Commercialization Hub

Wednesday, June 17, 2015

Source: BioSpace

As further evidence of Governor Andrew M. Cuomo's successful establishment of a dynamic and growing bio-pharma sector in Buffalo, New York, Albany Molecular Research Inc. (NASDAQ: AMRI) and PerkinElmer, Inc. today announced the formation of a strategic collaboration in connection with the opening of AMRI's drug discovery center as part of the new Buffalo Medical Innovation and Commercialization Hub (BMIC). Co-located on the Buffalo Niagara Medical Campus and part of the larger commitment by the State of New York with SUNY Polytechnic Institute, the Hub will accelerate drug discovery and innovation, and ultimately support the creation of more than 250 high tech jobs.

View All News »